Treatment and Prevention of Bone Metastases from Breast Cancer: A Comprehensive Review of Evidence for Clinical Practice
Published 2014 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Treatment and Prevention of Bone Metastases from Breast Cancer: A Comprehensive Review of Evidence for Clinical Practice
Authors
Keywords
-
Journal
Journal of Clinical Medicine
Volume 3, Issue 1, Pages 1-24
Publisher
MDPI AG
Online
2014-01-10
DOI
10.3390/jcm3010001
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Effects of denosumab versus zoledronic acid (ZA) on pain in patients (pts) with metastatic breast cancer: Results from a phase III clinical trial.
- (2017) A. Stopeck et al. JOURNAL OF CLINICAL ONCOLOGY
- Effect of adjuvant zoledronic acid (ZOL) on disseminated tumor cells (DTC) in the bone marrow (BM) of women with early-stage breast cancer (ESBC): Updated results.
- (2017) S. Greenberg et al. JOURNAL OF CLINICAL ONCOLOGY
- Abstract PD07-09: Zoledronate versus ibandronate comparative evaluation (ZICE) trial - first results of a UK NCRI 1,405 patient phase III trial comparing oral ibandronate versus intravenous zoledronate in the treatment of breast cancer patients with bone metastases.
- (2014) PJ Barrett-Lee et al. CANCER RESEARCH
- German Adjuvant Intergroup Node-Positive Study: A Phase III Trial to Compare Oral Ibandronate Versus Observation in Patients With High-Risk Early Breast Cancer
- (2013) Gunter von Minckwitz et al. JOURNAL OF CLINICAL ONCOLOGY
- Efficacy and safety of 12-weekly versus 4-weekly zoledronic acid for prolonged treatment of patients with bone metastases from breast cancer (ZOOM): a phase 3, open-label, randomised, non-inferiority trial
- (2013) Dino Amadori et al. LANCET ONCOLOGY
- Adjuvant Therapy With Zoledronic Acid in Patients With Breast Cancer: A Systematic Review and Meta-Analysis
- (2013) A. Valachis et al. ONCOLOGIST
- Single fraction conventional external beam radiation therapy for bone metastases: A systematic review of randomised controlled trials
- (2013) Kristopher Dennis et al. RADIOTHERAPY AND ONCOLOGY
- Zoledronic acid (zoledronate) for postmenopausal women with early breast cancer receiving adjuvant letrozole (ZO-FAST study): final 60-month results
- (2012) R. Coleman et al. ANNALS OF ONCOLOGY
- Oral clodronate for adjuvant treatment of operable breast cancer (National Surgical Adjuvant Breast and Bowel Project protocol B-34): a multicentre, placebo-controlled, randomised trial
- (2012) Alexander HG Paterson et al. LANCET ONCOLOGY
- Global cancer statistics
- (2011) Ahmedin Jemal et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Final 5-year results of Z-FAST trial
- (2011) Adam M. Brufsky et al. CANCER
- Immediate Administration of Zoledronic Acid Reduces Aromatase Inhibitor–Associated Bone Loss in Postmenopausal Women With Early Breast Cancer: 12-Month Analysis of the E-ZO-FAST Trial
- (2011) Antonio Llombart et al. Clinical Breast Cancer
- The efficacy of zoledronic acid in breast cancer adjuvant therapy: A meta-analysis of randomised controlled trials
- (2011) Tingting Yan et al. EUROPEAN JOURNAL OF CANCER
- Palliative Radiotherapy for Bone Metastases: An ASTRO Evidence-Based Guideline
- (2011) Stephen Lutz et al. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
- American Society of Clinical Oncology Executive Summary of the Clinical Practice Guideline Update on the Role of Bone-Modifying Agents in Metastatic Breast Cancer
- (2011) Catherine H. Van Poznak et al. JOURNAL OF CLINICAL ONCOLOGY
- Adjuvant endocrine therapy plus zoledronic acid in premenopausal women with early-stage breast cancer: 62-month follow-up from the ABCSG-12 randomised trial
- (2011) Michael Gnant et al. LANCET ONCOLOGY
- Breast-Cancer Adjuvant Therapy with Zoledronic Acid
- (2011) Robert E. Coleman et al. NEW ENGLAND JOURNAL OF MEDICINE
- Everolimus in Postmenopausal Hormone-Receptor–Positive Advanced Breast Cancer
- (2011) José Baselga et al. NEW ENGLAND JOURNAL OF MEDICINE
- Zoledronic Acid in the Treatment of Early-Stage Breast Cancer: Is There a Final Verdict?
- (2011) Michael Gnant Current Oncology Reports
- Zoledronic acid in breast cancer: latest findings and interpretations
- (2011) Michael Gnant Therapeutic Advances in Medical Oncology
- A review of the clinical implications of bisphosphonates in dentistry
- (2010) GL Borromeo et al. AUSTRALIAN DENTAL JOURNAL
- Combining Src inhibitors and aromatase inhibitors: A novel strategy for overcoming endocrine resistance and bone loss
- (2010) Stephen Hiscox et al. EUROPEAN JOURNAL OF CANCER
- Denosumab Compared With Zoledronic Acid for the Treatment of Bone Metastases in Patients With Advanced Breast Cancer: A Randomized, Double-Blind Study
- (2010) Alison T. Stopeck et al. JOURNAL OF CLINICAL ONCOLOGY
- Effect of zoledronic acid on disseminated tumour cells in women with locally advanced breast cancer: an open label, randomised, phase 2 trial
- (2010) Rebecca Aft et al. LANCET ONCOLOGY
- Personalized medicine in oncology: the future is now
- (2010) Richard L. Schilsky NATURE REVIEWS DRUG DISCOVERY
- Examining the Metastatic Niche: Targeting the Microenvironment
- (2010) Theresa Guise SEMINARS IN ONCOLOGY
- Denosumab in Breast Cancer
- (2010) Allan Lipton Current Oncology Reports
- Third consensus on medical treatment of metastatic breast cancer
- (2009) S. Beslija et al. ANNALS OF ONCOLOGY
- Latent Bone Metastasis in Breast Cancer Tied to Src-Dependent Survival Signals
- (2009) Xiang H.-F. Zhang et al. CANCER CELL
- Tumor Self-Seeding by Circulating Cancer Cells
- (2009) Mi-Young Kim et al. CELL
- Adjuvant bisphosphonates in breast cancer: Are we witnessing the emergence of a new therapeutic strategy?
- (2009) R.E. Coleman EUROPEAN JOURNAL OF CANCER
- Randomized Phase II Trial of Denosumab in Patients With Bone Metastases From Prostate Cancer, Breast Cancer, or Other Neoplasms After Intravenous Bisphosphonates
- (2009) Karim Fizazi et al. JOURNAL OF CLINICAL ONCOLOGY
- Endocrine Therapy plus Zoledronic Acid in Premenopausal Breast Cancer
- (2009) Michael Gnant et al. NEW ENGLAND JOURNAL OF MEDICINE
- Smad2 and Smad3 have opposing roles in breast cancer bone metastasis by differentially affecting tumor angiogenesis
- (2009) M Petersen et al. ONCOGENE
- Adjuvant oral clodronate improves the overall survival of primary breast cancer patients with micrometastases to the bone marrow--a long-term follow-up
- (2008) I. J. Diel et al. ANNALS OF ONCOLOGY
- Transforming growth factor-β signaling: emerging stem cell target in metastatic breast cancer?
- (2008) Antoinette R. Tan et al. BREAST CANCER RESEARCH AND TREATMENT
- In vivo effects of zoledronic acid on peripheral γδ T lymphocytes in early breast cancer patients
- (2008) Daniele Santini et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Subtypes of Breast Cancer Show Preferential Site of Relapse
- (2008) M. Smid et al. CANCER RESEARCH
- Exploring the anti-tumour activity of bisphosphonates in early breast cancer
- (2008) M.C. Winter et al. CANCER TREATMENT REVIEWS
- The Bone Marrow Microenvironment as a Tumor Sanctuary and Contributor to Drug Resistance
- (2008) M. B. Meads et al. CLINICAL CANCER RESEARCH
- Molecular mechanisms and treatment of bone metastasis
- (2008) Gregory A. Clines et al. EXPERT REVIEWS IN MOLECULAR MEDICINE
- Bone metastasis is strongly associated with estrogen receptor–positive/progesterone receptor–negative breast carcinomas
- (2008) Bing Wei et al. HUMAN PATHOLOGY
- Randomized Trial of Denosumab in Patients Receiving Adjuvant Aromatase Inhibitors for Nonmetastatic Breast Cancer
- (2008) Georgiana K. Ellis et al. JOURNAL OF CLINICAL ONCOLOGY
- Trends in Survival Over the Past Two Decades Among White and Black Patients With Newly Diagnosed Stage IV Breast Cancer
- (2008) Shaheenah Dawood et al. JOURNAL OF CLINICAL ONCOLOGY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationPublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More